Keywords: BASF, Catalent Pharma, Collaboration, Bioavailability, NMEs, Solubility, Permeability, Drug formulation

BASF and Catalent join forces to address NME bioavailability challenges

Article | 04 April 2012

Print This

Privately-held USA-based Catalent Pharma Solutions has joined forces with German drug giant BASF (BAS: DE) in a broad collaboration to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in